Study of Transverse Abdominis Plane (TAP) Block in Children Undergoing Hydrocelectomy and/or Hernia Repair Surgery (TAP)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01698268 |
|
Recruitment Status :
Completed
First Posted : October 2, 2012
Results First Posted : June 19, 2017
Last Update Posted : August 24, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Hydrocele Inguinal Hernia | Procedure: TAP block Procedure: Local Infiltration | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 50 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Primary Purpose: | Treatment |
| Official Title: | The Efficacy of Transverse Abdominis Plane (TAP) Block in Children Undergoing Hydrocelectomy and/or Hernia Repair |
| Study Start Date : | February 2012 |
| Actual Primary Completion Date : | November 2014 |
| Actual Study Completion Date : | November 2014 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: TAP Group
Enrolled subjects will receive a TAP block with 0.5cc/kg of 0.25% ropivacaine.
|
Procedure: TAP block
TAP Block will be performed under ultrasound guidance via Sonosite device with an in-plane technique by the anesthesiologist. |
|
Active Comparator: Local Infiltration Group
Enrolled subjects will receive will receive local infiltration of 0.5 cc/kg of 0.25% ropivacaine.
|
Procedure: Local Infiltration
Local infiltration of 0.5 cc/kg of 0.25% ropivacaine will be administered by the surgeon. |
- FLACC: Face, Legs, Activity, Cry, and Consolability Pain Assessment Scale (FLACC) [ Time Frame: Admission into PACU ]FLACC: Face, Legs, Activity, Cry, and Consolability Pain Assessment Scale (FLACC), a five-item, three point scale that measures pain behavior on a scale of 0 - 2 which are summed to result in a total score of 0 - 10. Clinical judgment is used to interpret pain. The higher the score on the FLACC correlates with a higher pain score (0= no behaviors indicative of pain and 10= five behaviors indicative of significant pain). This scale was evaluated by blinded post-operative anesthesia care unit (PACU) Registered Nurses (RNs) at admission to PACU.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 2 Years to 8 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Children 2-8 years of age
- Elective inguinal hernia repair, inguinal hernia repair with peritoneoscopy and/or hydrocelectomy to be performed in the Center for Children's Surgery, Beaumont Hospital, Royal Oak
- American Society of Anesthesiologists physical status classification 1 and 2 (patients that have either no systemic illness, or mild systemic disease that is well controlled, eg. mild asthma)
Exclusion Criteria:
- History of allergy to study medications
- Enrollment in concurrent research study
- Pregnant patients*
- Students/trainees/staff*
- Mentally disabled/cognitively impaired*
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01698268
| United States, Michigan | |
| Beaumont Health System | |
| Royal Oak, Michigan, United States, 48073 | |
| Principal Investigator: | Kaveh Aslani, MD | Beaumont Health System |
| Responsible Party: | Kaveh Aslani, MD, Principal Investigator, William Beaumont Hospitals |
| ClinicalTrials.gov Identifier: | NCT01698268 |
| Other Study ID Numbers: |
2011-213 |
| First Posted: | October 2, 2012 Key Record Dates |
| Results First Posted: | June 19, 2017 |
| Last Update Posted: | August 24, 2017 |
| Last Verified: | July 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Hernia Hernia, Inguinal Pathological Conditions, Anatomical Hernia, Abdominal |

